Upstream Bio, Inc. (UPB)

CIK 0002022626 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-13) · 99.1
Latest FY-2025 8-K (2026-03-26) · 99.1  |  8-K (2026-02-11) · 99.1
Q3-2025 8-K (2025-11-05) · 99.1
Q2-2025 8-K (2025-08-06) · 99.1
Q1-2025 8-K (2025-05-06) · 99.1
FY-2024 8-K (2025-03-12) · 99.1
Q3-2024 8-K (2024-11-07) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (unaudited)
—
Condensed Consolidated Statements of Stockholders' Deficit (unaudited)
—
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit)
—
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (P) (unaudited)
—
Consolidated Statements of Cash Flows
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit) (P)
—
Consolidated Statements of Cash Flows (P)
Notes
Accrued Expenses and Other Current Liabilities
Commitments and Contingencies
Common Stock
Cybersecurity Risk Management, Strategy, and Governance
—
Employee Benefit Plan
—
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Leases
License Agreements
Nature of The Business and Basis of Presentation
Net Loss Per Share
Pay Vs Performance Disclosure
Prepaid Expenses and Other Current Assets
Property and Equipment, Net
Redeemable Convertible Preferred Stock
Related Parties
Revenue
Segment Reporting
Stock-based Compensation
Subsequent Events
—
Summary of Significant Accounting Policies